Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in: Adults with chronic immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough. Children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove the spleen have not worked well enough.
Romiplostim is the generic name for the trade name drug Nplate. Romiplostim is indicated as a potential treatment for chronic idiopathic (immune) thrombocytopenic purpura (ITP). On August 22, 2008, the FDA approved romiplostim as a long-term treatment for chronic ITP in adults who have not responded to other treatments, such as corticosteroids, intravenous immunoglobulin, Rho(D) immune globulin or splenectomy.
Trade Name: NPLATE® (romiplostim) for injection, for subcutaneous use. Initial U.S. Approval: 2008
Generic Name: Romiplostin
For injection: 125 mcg, 250 mcg or 500 mcg of deliverable romiplostim as a lyophilized powder in single-dose vials.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Nplate (Romiplostin) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
The order for Nplate (Romiplostin) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA. Indian Pharma Network (IPN) act as a facilitator for you, under Named Patient Supply for anti-cancer medicines.
For overseas patient "Nplate (Romiplostin)" brands can be also made available to overseas patients, doctors and hospitals at China, Cambodia, Indonesia, Nepal, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.